Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
about
Water dispersible microbicidal cellulose acetate phthalate filmA systematic review and meta-analysis of risk factors for sexual transmission of HIV in IndiaFrom epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California.Herpes simplex virus type 2 risks in female sex workers in the China-Vietnam border county of Hekou.Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa.HIV infection and STD in drug addicted prostitutes in Amsterdam: potential for heterosexual HIV transmission.Increase of infectious syphilis among heterosexuals in Amsterdam: its relationship to drug use and prostitution.Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition.HIV prevalence among clients attending a sexually transmitted diseases clinic in Amsterdam: the potential risk for heterosexual transmissionThe prevalence of human retroviral infections in female patients attending a central London sexually transmitted disease clinic: 1985-1990.The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991.Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men.Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women.Genital herpes: review of the epidemic and potential use of type-specific serologyHerpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons.Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India.Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trialDetection of transmission clusters of HIV-1 subtype C over a 21-year period in Cape Town, South AfricaVirus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.Counseling patients about HIV risk from oral sexAntiviral activity of a single-domain antibody immunotoxin binding to glycoprotein D of herpes simplex virus 2.Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa.HIV seroprevalence surveys in sexually transmitted disease clinicsHerpes simplex virus type 2: Seroprevalence in antenatal womenHeterosexual transmission of human immunodeficiency virus (HIV) in the United States.Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa.STD in Bangladesh's trucking industry: prevalence and risk factors.Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIVHeterosexual transmission of human immunodeficiency virus infection - Strategies for prevention.Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model.Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men.The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.Herpes simplex virus type 2: epidemiology and management options in developing countries.Interactions and management issues in HSV and HIV coinfection.The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes.A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.
P2860
Q24799617-9AFE0AC8-B1ED-4B96-8BCB-9CE1A964BE56Q27025229-D0FD08A9-9046-4CE9-BC86-690FAB5CE2E3Q33711635-7F2FA4C9-9429-4290-A2FD-C65803F0EF2EQ33727684-69238D83-D3AD-49F7-8181-9E55DB04E63EQ33777091-0CAFC9BA-0442-44C6-B8F0-D703C1875859Q33810615-1D848AE7-21D9-4A31-8497-27FE520666D9Q33816722-EFB20145-FC98-41D5-B46A-3016A73EFAD4Q33846776-BA57AEC8-F43B-4667-BD30-38B95942E370Q33932050-3988046F-17F1-40C8-8DF7-18E2DA8AC6C0Q33932449-52B6C83D-F1A1-4C53-8F2C-CCAE6B0D901FQ33932774-B8070C29-4B5E-454D-87DD-A062CD79BAE9Q33934183-10386164-1508-48FA-A947-9E86D40D423CQ33934193-B63CC6EC-970C-4C67-96D0-4617D1DCE6BBQ33934554-074DC15E-925F-4709-954F-E2E1B1E6B108Q33935624-AF188063-22F1-479E-B86B-3827EFACC749Q33935776-BBC0347E-5C9E-471A-B6E5-20321125B159Q33975387-CBD95286-64C5-40E0-9C01-F9F199B1D385Q34071917-3562B2BF-D74C-4466-B666-C9ADC331B3FAQ34082025-0C88C4E4-11FE-4ED4-B6C2-B94D5DCFDCE9Q34408313-A4ADA448-A0AB-4DAF-9395-B95FBFC65953Q34428077-46C06AD6-A0FF-4B21-A69C-983DE9DD7DCCQ34653920-FF428044-347A-4BDE-ADC9-303417DDF0D7Q34753877-8BDC2F0C-E06E-4EA4-AC6E-8424700492EDQ34923432-5958CBA7-2741-49EB-A742-DBE54FEE7A69Q35007321-F740CA71-0A7C-4BC3-9CD2-7B869D0C7081Q35054683-097B7146-4423-4424-ADBC-9FE3F688FFA9Q35117278-8E5FA728-D3AD-4A47-9F2E-A1BA30257866Q35121471-B57107A3-5AD5-4BB8-8B74-8566D3FCB62CQ35530686-62E42B21-1D68-4628-AEB6-F0469C8EB5C0Q35572920-750A3D17-E659-4DB7-B198-8AFCB58C4F29Q35708939-26F9D418-3FCE-4B41-8651-DADB83AE0451Q35839161-FC407BBF-1F86-4DA3-A10B-2ADE6951346EQ35883842-C5606E32-28C4-4E39-A967-931D027601FDQ36079480-D030AA48-5477-4C2C-818E-4377F746B602Q36571976-3C113055-70FD-4A71-9793-2C242CFA59D2Q36650973-205E3C95-39DA-4930-8408-12F12542270AQ36777844-8267351D-397C-4C47-A24E-1117804899B9Q36827125-16F27FBB-3CEE-46E5-8B2B-78A0301F097CQ36845870-1E67B223-8C27-4F92-BD76-F005D599B7D4Q37070372-65C31F7F-6EB6-4395-AC6D-7A6EB4E95B4F
P2860
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
@en
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
@nl
type
label
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
@en
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
@nl
prefLabel
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
@en
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
@nl
P2093
P1476
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection.
@en
P2093
A J Nahmias
A R Gerber
J A Stewart
P M O'Malley
S D Holmberg
P304
P356
10.1001/JAMA.1988.03720070048033
P407
P577
1988-02-01T00:00:00Z